Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carroll

Blood

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Blood|August 22, 2009
Taking aim at protein translation in AMLMartin Carroll
Blood|June 30, 2012
BCR/ABL and chromosomal instability: debate resolvedMartin Carroll
Blood|July 24, 2020
A common protein target for an uncommon subtype of AMLMartin Carroll
Blood|February 8, 2007
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsDuonan Yu, Martin Carroll, Andrei Thomas-Tikhonenko
Blood|September 10, 2005
mTOR regulates cell survival after etoposide treatment in primary AML cellsQing Xu, James E Thompson, Martin Carroll
Blood|February 28, 2002
TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycleJamil Dierov, Qing Xu, Raia Dierova, et al.
Blood|April 19, 2003
Survival of acute myeloid leukemia cells requires PI3 kinase activationQing Xu, Serge-Emile Simpson, Timothy J Scialla, et al.
Blood|August 9, 2011
Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptorSabyasachi Bhattacharya, Hui Zheng, Christos Tzimas, et al.
Blood|February 29, 2008
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataDuane C Hassane, Monica L Guzman, Cheryl Corbett, et al.
Blood|October 1, 2005
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALLDavid T Teachey, Dana A Obzut, Jonathan Cooperman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Blood|August 22, 2009
Taking aim at protein translation in AMLMartin Carroll
Blood|June 30, 2012
BCR/ABL and chromosomal instability: debate resolvedMartin Carroll
Blood|July 24, 2020
A common protein target for an uncommon subtype of AMLMartin Carroll
Blood|February 8, 2007
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsDuonan Yu, Martin Carroll, Andrei Thomas-Tikhonenko
Blood|September 10, 2005
mTOR regulates cell survival after etoposide treatment in primary AML cellsQing Xu, James E Thompson, Martin Carroll
Blood|February 28, 2002
TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycleJamil Dierov, Qing Xu, Raia Dierova, et al.
Blood|April 19, 2003
Survival of acute myeloid leukemia cells requires PI3 kinase activationQing Xu, Serge-Emile Simpson, Timothy J Scialla, et al.
Blood|August 9, 2011
Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptorSabyasachi Bhattacharya, Hui Zheng, Christos Tzimas, et al.
Blood|February 29, 2008
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataDuane C Hassane, Monica L Guzman, Cheryl Corbett, et al.
Blood|October 1, 2005
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALLDavid T Teachey, Dana A Obzut, Jonathan Cooperman, et al.
Pageof 3